Isolation of linoleic acid as an estrogenic compound from the fruits of Vitex agnus-castus L. (chaste-berry).
D001943:Breast Neoplasms / Q000188:drug therapy / Q000473:pathology; D045744:Cell Line, Tumor / Q000187:drug effects; D017931:DNA Primers; D016889:Endometrial Neoplasms / Q000188:drug therapy / Q000473:pathology; D004965:Estrogen Antagonists / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D047628:Estrogen Receptor alpha; D047629:Estrogen Receptor beta; D005260:Female; D005638:Fruit; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D019787:Linoleic Acid / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy / Q000473:pathology; D008517:Phytotherapy; D010936:Plant Extracts / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D012333:RNA, Messenger / Q000187:drug effects; D011960:Receptors, Estrogen / Q000187:drug effects* / Q000235:genetics; D011980:Receptors, Progesterone / Q000187:drug effects* / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction; D020950:Vitex
D017931:DNA Primers; D004965:Estrogen Antagonists; D047628:Estrogen Receptor alpha; D047629:Estrogen Receptor beta; D010936:Plant Extracts; D012333:RNA, Messenger; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D019787:Linoleic Acid